Cronos Group Inc. - Common Share (CRON)
2.0500
0.00 (0.00%)
Cronos Group is a leading global cannabinoid company focused on the research, development, and production of smoked and non-smoked cannabis products
The company operates multiple brands and offers a wide range of cannabis-based products, including oils, capsules, and edibles, catering to both medicinal and recreational markets. Cronos Group is committed to innovative research and development efforts aimed at advancing the cannabis industry, and it emphasizes sustainability and compliance with regulatory standards across its operations. By leveraging strategic partnerships and investments in technology, the company seeks to enhance its market presence and drive growth in the evolving landscape of cannabis consumption.
![](https://cdn.benzinga.com/files/images/story/2025/02/05/Portadas-Javi-Benzinga61.png?width=1200&height=800&fit=crop)
Aurora Cannabis (NASDAQACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Via Benzinga · February 5, 2025
![](https://cdn.pixabay.com/photo/2015/07/11/00/38/chart-840331_960_720.jpg)
Income investors looking for a high dividend stock for 2025 should consider Altria Group Inc. The company has a long history of reliable dividend hikes.
Via Talk Markets · January 15, 2025
![](/next-assets/images/schema-image-default.png)
Via Benzinga · January 1, 2025
![](https://cdn.benzinga.com/files/images/story/2024/12/05/AI-Generated-Image_0.jpeg?width=1200&height=800&fit=crop)
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/14/Captura-de-pantalla-2024-11-14-a-las-15-.png?width=1200&height=800&fit=crop)
Cronos CEO Mike Gorenstein discusses Trump's potential for cannabis reform, challenges the "blue state" myth, and Cronos' focus...
Via Benzinga · November 14, 2024
In the third quarter, Cronos' Spinach brand became the best-selling cannabis brand in the Canadian adult-use market and their Peace Naturals brand held a top spot in the Israeli medical market.
Via Talk Markets · November 13, 2024
![](https://g.foolcdn.com/editorial/images/797575/chalboard-drawings-of-a-marijuana-leaf-with-accompanying-stock-bar-and-pie-charts.jpg)
Cronos stock just went up -- a lot. Maybe it's time to sell?
Via The Motley Fool · November 12, 2024
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
CRON earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 12, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/12/cannabis-msos.png?width=1200&height=800&fit=crop)
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via Benzinga · November 12, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/12/elsa-olofsson-12-Zs1xIEtA-unsplash22.jpeg?width=1200&height=800&fit=crop)
Cronos' Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared to a net loss of $1.6 million in the prior year's period. The company has set an operating expense savings target of $5 to $10 million for 2024,
Via Benzinga · November 12, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/31/cannabis-stocks_0.png?width=1200&height=800&fit=crop)
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via Benzinga · October 31, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/29/AI-Generated-Image.jpeg?width=1200&height=800&fit=crop)
Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.
Via Benzinga · October 29, 2024
![](https://talkmarkets.com/images/logos/talkmarkets.png)
The past, present and future of the Canadian cannabis sector
Via Talk Markets · October 7, 2024
Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis. As such, our conservative cannabis portfolio is just that - a conservative cannabis investment.
Via Talk Markets · September 16, 2024
The Canadian Cannabis LP Stocks Portfolio was up +6% last week from a 10% decline w/e Sept. 6th as the negative sentiment waned surrounding the DEA's announcement that it would be having a December 2nd hearing to consider additional opinions
Via Talk Markets · September 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/09/AI-Generated-Image_1.jpeg?width=1200&height=800&fit=crop)
The Canadian cannabis market is shifting towards newer product formats, with some segments outperforming cannabis flowers in sales.
Via Benzinga · September 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/09/AI-Generated-Image_0.jpeg?width=1200&height=800&fit=crop)
Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.
Via Benzinga · September 9, 2024
Our LP portfolio was down 10% last week as a result of the August 26th announcement by the DEA that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on the proposal that cannabis be re-classified.
Via Talk Markets · September 9, 2024